Cgi Emergency Use Approval For Aviptadil News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Read more about Biophore applies for DCGI emergency-use approval for Covid treatment drug on Business Standard. Biophore India Pharmaceuticals on Friday said it has applied to the Drugs Controller General of India (DCGI) for obtaining emergency-use approval for Aviptadil, used in Covid treatment

Andhra pradeshJagadeesh babu rangisettyBiophore india pharmaceuticals onBiophore india pharmaceuticalsDrugs controller generalActive pharmaceutical ingredientVasoactive intestinal peptideBabu rangisettySulfobutyl etherDrug controller general of indiaCgi emergency use approval for aviptadilCovid 19 treatment drugஆந்திரா பிரதேஷ்மருந்துகள் கட்டுப்படுத்தி ஜநரல்செயலில் மருந்து மூலப்பொருள்